NCT04801251

Brief Summary

The study done to identify the relation between the presence of abnormal clinical cardiac findings and the echocardiographic findings in newborn infants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 16, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

October 20, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

March 8, 2021

Last Update Submit

September 10, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Red flags for cardiac examination

    A complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination. Methods: 1. Echocardiogram reports will be reviewed and cardiovascular abnormalities will be noted. The presence of patent ductus arteriosus (PDA) will be considered a normal finding if present at ≤ 7 days of age but not beyond. A patent foramen ovale will be considered normal. A small muscular ventricular septal defect (VSD), although common in neonates and, will be considered an abnormal finding. 2. All patients will have pulse oximeter screening, newborns with pulse oximetry ≥ 95% in the right hand or foot and ≤ 3% difference between the right hand and either foot at any time of testing have a normal result, and require no further testing.

    1 year

  • The importance of history in detecting congenital heart disease

    A full history will be taken, family history of congenital heart disease, mother's age and consanguinity, gravidity and parity should also be included. A File will be prepared for each neonate, which consist of demographic details including cardiac physical examination findings, birth weight, fetal age, history of folic acid intake by the mother, family history of cardiac disease, pulse oximeter screening, and results will be recorded. Data will be collected in form of taking history by interviewing questionnaire and full clinical examination will be done particularly cardiac examination and all findings will be recorded in patient clinical checklist. X\^2 will be used to compare frequencies among different categories. Student T test, ANOVA will be used to test differences between means. ALL statistical analysis will be performed by using the SPSS version 20. P value \<0.05 will be considered statistically significant for all applied statistical tests.

    1 year

Study Arms (2)

Resident

OTHER

Full history.complete systemic and cardiac physical examination

Diagnostic Test: Echocardiographic examination

Assistant Lecturer

OTHER

Echocardiographic examination

Diagnostic Test: Echocardiographic examination

Interventions

Each patient included will undergo full cardiac physical examination and echocardiographic examination

Also known as: Full physical and cardiac examination
Assistant LecturerResident

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Abnormal heart rate (\< 90/min or \< 160 per min )
  • Comfortable tachypnea ( RR \> 60/min without other manifestations of respiratory distress)
  • Abnormal heart sounds (muffled, accentuated, single )
  • Abnormal precordial activity
  • Murmur: ( ≥ grade 3 intenisty, holosystolic timing, maximum intensity at upper left sternal border or with upright positing, diastolic murmur, harsh or blowing quality )
  • Abnormal oxygen saturation \<90% in any extremity Oxygen saturation gradient \> 3% difference in extremities.
  • Blood pressure gradient \>10 mmHg higher in arms \>10 mmHg lower in legs
  • Abnormal femoral pulses
  • Weakened pulses
  • Absent pulses
  • Hepatomegaly
  • Family history of cardiac disease

You may not qualify if:

  • Newborns with disorders affecting the heart as anemia, septicemia, respiratory disorders as respiratory distress syndrome, pneumonia, hypoplastic lung, renal impairment, hypertension, metabolic disease, syndromatic CHF

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr. 2017 Mar;15(1):13-17. doi: 10.1007/s12574-016-0308-2. Epub 2016 Aug 16.

  • Hiremath G, Kamat D. When to call the cardiologist: treatment approaches to neonatal heart murmur. Pediatr Ann. 2013 Aug;42(8):329-33. doi: 10.3928/00904481-20130723-13. No abstract available.

  • Triedman JK, Newburger JW. Trends in Congenital Heart Disease: The Next Decade. Circulation. 2016 Jun 21;133(25):2716-33. doi: 10.1161/CIRCULATIONAHA.116.023544. No abstract available.

Related Links

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nagwa Ali, Professor

    Assiut University

    STUDY DIRECTOR
  • Amira Shalaby, Lecturer

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Sarah Bakry, Resident

CONTACT

Amira Shalaby, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: The relation between the presence of abnormal clinical cardiac findings and the abnormal echocardiographic findings
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

March 8, 2021

First Posted

March 16, 2021

Study Start

October 20, 2021

Primary Completion

October 20, 2022

Study Completion

December 20, 2022

Last Updated

September 14, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

A full history will be taken, complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
starting one year after publication
Access Criteria
all collected IPD, all IPD that underlie results in a publication

Available IPD Datasets

Study Protocol (Sarah bakry)Access